BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3958980)

  • 1. The hypothalamo-hypophyseal rat explant in vitro: endocrinological studies of the pars intermedia dopaminergic neural input.
    Davis MD
    J Physiol; 1986 Jan; 370():381-93. PubMed ID: 3958980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamohypophyseal system in vitro: electrophysiology of the pars intermedia and evidence for both excitatory and inhibitory inputs.
    Davis MD; Haas HL; Lichtensteiger W
    Brain Res; 1985 May; 334(1):97-104. PubMed ID: 2986782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1978; 25(5):275-90. PubMed ID: 206853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amines and control of melanophore stimulating hormone release.
    Bower A; Hadley ME; Hruby VJ
    Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct neural control of MSH secretion in mammals: the involvement of dopaminergic tubero-hypophysial neurones.
    Tilders FJ; Smelik PG
    Front Horm Res; 1977; 4():80-93. PubMed ID: 26617
    [No Abstract]   [Full Text] [Related]  

  • 6. Postsynaptic potentials mediated by GABA and dopamine evoked in stellate glial cells of the pituitary pars intermedia.
    Mudrick-Donnon LA; Williams PJ; Pittman QJ; MacVicar BA
    J Neurosci; 1993 Nov; 13(11):4660-8. PubMed ID: 8229191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early postnatal development of pituitary intermediate lobe control in the rat by dopamine neurons.
    Davis MD; Lichtensteiger W; Schlumpf M; Bruinink A
    Neuroendocrinology; 1984 Jul; 39(1):1-12. PubMed ID: 6462368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hypothalamic lesions on immuno-reactive alpha-melanocyte stimulating hormone secretion in the rat.
    Penny RJ; Tilders FJ; Thody AJ
    J Physiol; 1979 Jul; 292():59-67. PubMed ID: 490393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary.
    Goudreau JL; Lindley SE; Lookingland KJ; Moore KE
    Neuroendocrinology; 1992 Jul; 56(1):100-5. PubMed ID: 1322505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action potentials in gland cells of rat pituitary pars intermedia: inhibition by dopamine, an inhibitor of MSH secretion.
    Douglas WW; Taraskevich PS
    J Physiol; 1978 Dec; 285():171-84. PubMed ID: 745066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat.
    Tilders FJ; van der Woude HA; Swaab DF; Mulder AH
    Brain Res; 1979 Aug; 171(3):425-35. PubMed ID: 38880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA and GABAB receptor-mediated inhibition of release of 5-hydroxytryptamine in the intermediate lobe of the rat pituitary gland.
    Racké K; Holzbauer M; Sharman DF; Cooper TR
    Neuroscience; 1987 Nov; 23(2):679-84. PubMed ID: 2830560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA and dopamine act directly on melanotropes of Xenopus to inhibit MSH secretion.
    Verburg-Van Kemenade BM; Jenks BG; Driessen AG
    Brain Res Bull; 1986 Nov; 17(5):697-704. PubMed ID: 3801932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous dopamine and serotonin release from the explanted rat tuberohypophyseal system: effects of electrical stimulation and neurotensin.
    Davis MD; Kilts CD
    Life Sci; 1987 May; 40(19):1869-74. PubMed ID: 3573983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The intermediate lobe of the pituitary, model of neuroendocrine communication].
    Lamacz M; Tonon MC; Louiset E; Cazin L; Vaudry H
    Arch Int Physiol Biochim Biophys; 1991 Jun; 99(3):205-19. PubMed ID: 1717055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2-like dopamine receptor mediates dopaminergic or gamma-aminobutyric acidergic inhibition of melanotropin-releasing hormone release from the pars intermedia in frogs (Rana nigromaculata).
    Tonosaki Y; Nishiyama K; Honda T; Ozaki N; Sugiura Y
    Endocrinology; 1995 Dec; 136(12):5260-5. PubMed ID: 7588269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual population of GABAA and GABAB receptors in rat pars intermedia demonstrated by release of alpha MSH caused by barium ions.
    Demeneix BA; Desaulles E; Feltz P; Loeffler JP
    Br J Pharmacol; 1984 May; 82(1):183-90. PubMed ID: 6329387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic inhibition of the pituitary release of adrenocorticotropin and alpha-melanotropin is impaired in dogs with hepatic encephalopathy.
    Rothuizen J; de Kok Y; Slob A; Mol JA
    Domest Anim Endocrinol; 1996 Jan; 13(1):59-68. PubMed ID: 8625616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of melanotropin release from the pars intermedia of the amphibian Xenopus laevis: evaluation of the involvement of serotonergic, cholinergic, or adrenergic receptor mechanisms.
    Verburg-van Kemenade BM; Jenks BG; van Overbeeke AP
    Gen Comp Endocrinol; 1986 Sep; 63(3):471-80. PubMed ID: 3557070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innervation of the pars intermedia and control of alpha-melanotropin secretion in the newt.
    Danger JM; Perroteau I; Franzoni MF; Saint-Pierre S; Fasolo A; Vaudry H
    Neuroendocrinology; 1989 Nov; 50(5):543-9. PubMed ID: 2514395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.